Holen Sie sich die Stockscreener-App
79.64
1.45%
1.135
Schlusskurs vom Vortag:
$78.50
Offen:
$78.48
24-Stunden-Volumen:
1.71M
Relative Volume:
0.78
Marktkapitalisierung:
$15.40B
Einnahmen:
$29.52M
Nettoeinkommen (Verlust:
$-567.06M
KGV:
-21.76
EPS:
-3.66
Netto-Cashflow:
$-551.11M
1W Leistung:
+2.42%
1M Leistung:
+34.21%
6M Leistung:
+98.11%
1J Leistung:
+68.37%
1-Tages-Spanne:
$77.89
$79.81
1-Wochen-Bereich:
$74.52
$79.81
52-Wochen-Spanne:
$29.17
$79.81
Revolution Medicines Inc Stock (RVMD) Company Profile
Firmenname
Revolution Medicines Inc
Sektor
Branche
Telefon
415-766-3638
Adresse
700 SAGINAW DR, REDWOOD CITY, CA
Vergleichen Sie RVMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
79.64 | 15.17B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-11-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-10-16 | Fortgesetzt | Stifel | Buy |
| 2025-09-12 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-09-05 | Eingeleitet | Truist | Buy |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-08-15 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2024-07-16 | Bestätigt | Needham | Buy |
| 2024-07-12 | Eingeleitet | Barclays | Overweight |
| 2024-07-08 | Eingeleitet | Jefferies | Buy |
| 2024-04-12 | Bestätigt | Needham | Buy |
| 2024-04-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-04 | Eingeleitet | Wedbush | Outperform |
| 2023-11-16 | Eingeleitet | Raymond James | Outperform |
| 2023-02-28 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-05-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-03-01 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-08-12 | Herabstufung | Goldman | Buy → Neutral |
| 2021-05-18 | Eingeleitet | Goldman | Buy |
| 2020-05-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-09 | Eingeleitet | Cowen | Outperform |
| 2020-03-09 | Eingeleitet | Guggenheim | Buy |
| 2020-03-09 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten
Revolution Medicines (RVMD) Up 27.9% Since Last Earnings Report: Can It Continue? - sharewise.com
Will Revolution Medicines Inc. Equity Warrant stock split attract more investors2025 Retail Activity & Weekly High Momentum Picks - Newser
Why Revolution Medicines Inc. Equity Warrant stock is favored by pension fundsJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Revolution Medicines (NASDAQ:RVMD) Hits New 52-Week HighShould You Buy? - MarketBeat
Why hedge funds are buying Revolution Medicines Inc. Equity Warrant stock2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Rhumbline Advisers Reduces Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 78.2 USD By Investing.com - Investing.com South Africa
Revolution Medicines stock hits all-time high at 78.2 USD - Investing.com India
TD Cowen reiterates Buy rating on Revolution stock, sees $5B+ opportunity - Investing.com UK
American Century Companies Inc. Has $16.72 Million Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Will Revolution Medicines Inc. (42Z) stock outperform value peers - Newser
Is Revolution Medicines Inc. (42Z) stock a contrarian opportunityAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Why Revolution Medicines Inc. stock could rally in 20252025 Big Picture & Real-Time Stock Entry Alerts - Newser
Franklin Resources Inc. Takes $9.26 Million Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Discipline and Rules-Based Execution in RVMD Response - news.stocktradersdaily.com
Swiss National Bank Cuts Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Is Revolution Medicines Inc Equity Warrant a good long term investmentFinancial Sector Performance & Market Trend Real-Time Reports - earlytimes.in
Revolution Medicines, Inc. $RVMD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Jefferies Financial Group Inc. Trims Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Mark Goldsmith Sells 60,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
XTX Topco Ltd Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Insider Sell: Jack Anders Sells Shares of Revolution Medicines I - GuruFocus
[Form 4] Revolution Medicines, Inc. Insider Trading Activity - Stock Titan
CFO Anders Sells 5,418 ($400.9K) Of Revolution Medicines Inc [RVMD] - TradingView
Universal Beteiligungs und Servicegesellschaft mbH Buys 5,060 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Magnetar Financial LLC - MarketBeat
Chmn Goldsmith Files To Sell 60,000 Of Revolution Medicines Inc [RVMD] - TradingView
Shareholder Goldsmith J Files To Sell 3,000 Of Revolution Medicines Inc [RVMD] - TradingView
Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week HighHere's What Happened - MarketBeat
Creative Planning Has $2.42 Million Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by ProShare Advisors LLC - MarketBeat
AXQ Capital LP Takes $282,000 Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 72.76 USD By Investing.com - Investing.com Nigeria
Revolution Medicines stock hits all-time high at 72.76 USD - Investing.com
Revolution Medicines IncOrdinary Shares (RVMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CapEx per share of Revolution Medicines, Inc. – BX:RVMD - TradingView
Revolution Medicines, Inc. $RVMD Shares Sold by Ensign Peak Advisors Inc - MarketBeat
Dynamic Technology Lab Private Ltd Has $801,000 Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Geode Capital Management LLC - MarketBeat
Revolution Medicines gets FDA Breakthrough Therapy status for daraxonrasib - MSN
Mark Goldsmith Sells 20,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Upgraded at Wolfe Research - MarketBeat
Revolution Medicines Reports Q3 2025 Financial Results - MSN
Why Revolution Medicines Inc. (42Z) stock could rally strongly2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Market reaction to Revolution Medicines Inc. Equity Warrant’s recent newsQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing - MarketScreener
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing - MarketScreener
Executives at Revolution Medicines Conduct Stock Transactions - TradingView
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):